article · 2014
Bevacizumab plus capecitabine in patients with progressive advanced well-differentiated neuroendocrine tumors of the gastro-intestinal (GI-NETs) tract (BETTER trial) – A phase II non-randomised trial
109 citationsDOI: https://doi.org/10.1016/j.ejca.2014.10.001